Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia

PURPOSE: We evaluated the efficacy and safety of nebivolol and rosuvastatin combination treatment in patients with hypertension and hyperlipidemia. PATIENTS AND METHODS: Eligible patients, after more than 4 weeks of therapeutic lifestyle change, were randomly assigned to three groups: 5 mg nebivolol...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Des Devel Ther
Hlavní autoři: Rhee, Moo-Yong, Kim, Cheol Ho, Ahn, Youngkeun, Shin, Joon-Han, Han, Seung Hwan, Kang, Hyun-Jae, Hong, Soon Jun, Kim, Hae-Young
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7680129/
https://ncbi.nlm.nih.gov/pubmed/33235439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S280055
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky